search
Documents
Chiral Screening of Drug Mix
In this technical note, we present various SFC screening approaches for the chiral separation of a 56-pharmaceutical compound test set using Lux polysaccharide-based chiral stationary phases. The new Lux Amylose-1 provides the largest number of baseline separations. Additional generic chiral separation strategies for SFC are highlighted for increasing success rates.
Chiral Screening of Drug Mix
In this technical note, we present various SFC screening approaches for the chiral separation of a 56-pharmaceutical compound test set using Lux polysaccharide-based chiral stationary phases. The new Lux Amylose-1 provides the largest number of baseline separations. Additional generic chiral separation strategies for SFC are highlighted for increasing success rates.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Chiral
Chiral Screening of Drug Mix
In this technical note, we present various SFC screening approaches for the chiral separation of a 56-pharmaceutical compound test set using Lux polysaccharide-based chiral stationary phases. The new Lux Amylose-1 provides the largest number of baseline separations. Additional generic chiral separation strategies for SFC are highlighted for increasing success rates.
| Target Industries: | Biopharmaceutical Analysis, Pharmaceutical |
| Techniques: | HPLC, HPLC-Chiral, SFC |
| Brands: | Axia, Lux, SecurityGuard |
| Separation Modes: | Chiral |
| Phases: | Lux Amylose-1, Lux Cellulose-1, Lux Cellulose-2, Lux Cellulose-3 , Lux Cellulose-4 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.